Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 5641 AL 5655

Persons with Alzheimer's disease make phone calls independently using a computer-aided telephone system

Perilli V, Lancioni GE, Singh NN, O'Reilly MF, Sigafoos J, Cassano G, Cordiano N, Pinto K, Minervini MG, Oliva D.

Res Dev Disabil. 2012 Jul-Aug;33(4):1014-20. doi: 10.1016/j.ridd.2012.01.007. Epub 2012 Feb 21.

Small-molecule BACE1 inhibitors: a patent literature review (2006 - 2011)

Probst G, Xu YZ.

Expert Opin Ther Pat. 2012 May;22(5):511-40. doi: 10.1517/13543776.2012.681302. Epub 2012 Apr 19.

Possible usefulness of growth hormone/insulin-like growth factor-I axis in Alzheimer's disease treatment

Sáez JM.

Endocr Metab Immune Disord Drug Targets. 2012 Sep;12(3):274-86. doi: 10.2174/187153012802002857.

Cotinine: a potential new therapeutic agent against Alzheimer's disease

Echeverria V, Zeitlin R.

CNS Neurosci Ther. 2012 Jul;18(7):517-23. doi: 10.1111/j.1755-5949.2012.00317.x. Epub 2012 Apr 25.

[Intended pharmacotherapeutical approaches of Alzheimer's disease therapy]

Korábecný J, Hrubá E, Soukup O, Zemek F, Musílek K, Nepovímová E, Spilovská K, Opletalová V, Kuca K.

Ceska Slov Farm. 2012 Feb;61(1-2):4-10.

The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of Technology Appraisal No. 111): a systematic review and economic model

Bond M, Rogers G, Peters J, Anderson R, Hoyle M, Miners A, Moxham T, Davis S, Thokala P, Wailoo A, Jeffreys M, Hyde C.

Health Technol Assess. 2012;16(21):1-470. doi: 10.3310/hta16210.

Effects of DHA-rich n-3 fatty acid supplementation on gene expression in blood mononuclear leukocytes: the OmegAD study

Vedin I, Cederholm T, Freund-Levi Y, Basun H, Garlind A, Irving GF, Eriksdotter-Jönhagen M, Wahlund LO, Dahlman I, Palmblad J.

PLoS One. 2012;7(4):e35425. doi: 10.1371/journal.pone.0035425. Epub 2012 Apr 24.

New and emerging treatments for Alzheimer's disease

Corbett A, Smith J, Ballard C.

Expert Rev Neurother. 2012 May;12(5):535-43. doi: 10.1586/ern.12.43.

[The best nursing science article of 2011]

Meyer G, Köpke S, Balzer K.

Pflege Z. 2012 Apr;65(4):193.

Is RAGE still a therapeutic target for Alzheimer's disease?

Deane RJ.

Future Med Chem. 2012 May;4(7):915-25. doi: 10.4155/fmc.12.51.

Gantenerumab for the treatment of Alzheimer's disease

Delrieu J, Ousset PJ, Vellas B.

Expert Opin Biol Ther. 2012 Aug;12(8):1077-86. doi: 10.1517/14712598.2012.688022. Epub 2012 May 15.

Anti-apoptotic and anti-oxidative mechanisms of minocycline against sphingomyelinase/ceramide neurotoxicity: implication in Alzheimer's disease and cerebral ischemia

Chen SD, Yin JH, Hwang CS, Tang CM, Yang DI.

Free Radic Res. 2012 Aug;46(8):940-50. doi: 10.3109/10715762.2012.674640. Epub 2012 May 28.

Review of theoretical studies for prediction of neurodegenerative inhibitors

Prado-Prado F, García I.

Mini Rev Med Chem. 2012 Jun;12(6):452-66. doi: 10.2174/138955712800493780.

Metal protein attenuating compounds for the treatment of Alzheimer's dementia

Sampson EL, Jenagaratnam L, McShane R.

Cochrane Database Syst Rev. 2012 May 16;5(5):CD005380. doi: 10.1002/14651858.CD005380.pub4.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias